PFSA logo

Profusa, Inc. Stock Price

NasdaqCM:PFSA Community·US$1.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PFSA Share Price Performance

US$0.41
-907.84 (-99.96%)
US$0.41
-907.84 (-99.96%)
Price US$0.41

PFSA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with weak fundamentals.

6 Risks
0 Rewards

Profusa, Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$36.6m

Other Expenses

-US$36.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-8.29
0%
0%
-44.5%
View Full Analysis

About PFSA

Founded
n/a
Employees
n/a
CEO
Ben Hwang
WebsiteView website
profusa.com

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Recent PFSA News & Updates

Recent updates

No updates